ADDvise Group calls for a change of the terms of the company’s senior secured bonds by initiation of a written procedure

16-12-2021   Regulatory press release

ADDvise Group AB (publ) (the "Company" and together with its subsidiaries from time to time, the "Group") has instructed the agent for the Company's up to SEK 500,000,000 senior secured bonds with ISIN SE0015222088 (the "Bonds") to initiate a written procedure to request that bondholders vote in favour of (i) amending and restating items (i) and (r) of the definition "Permitted Debt" in the terms and conditions of the Bonds (the "Terms and Conditions") and (ii) amending and restating item (f) of the definition "Permitted Security" in the Terms and Conditions (the "Proposal").

The proposed amendments will enable the Company to optimise the Group’s working capital financing and to limit the amount which must be paid upfront for future acquisitions. This will reduce the Group’s overall funding cost as well as the financial risk associated with acquisitions, allow the Company to continue to pursue attractive and sizeable acquisitions, and facilitate the overall continued growth of the Group.

Bondholders together representing approximately 50 per cent of the outstanding volume under the Bonds have expressed their support for the Proposal.

The agent will deliver the notice of a written procedure to all bondholders on 16 December 2021. The written procedure will commence on 22 December 2021 and end on 14 January 2022. To be eligible to participate in the written procedure a holder must fulfil the formal criteria for being a bondholder on 22 December 2021. This means that the holder must be registered on a securities account with Euroclear Sweden AB as a direct registered owner (Sw. direktregistrerad ägare) or authorised nominee (Sw. förvaltare) with respect to one or several Bonds.

Pareto Securities AB has been retained as financial advisor in connection with the written procedure.

The notice of a written procedure is available on the Company's website (addvisegroup.com) and on website of the agent (intertrustgroup.com).

For further information, please contact:

Rikard Akhtarzand, CEO
+46 765-25 90 71

rikard.akhtarzand@addvisegroup.se

About ADDvise Group

ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The group consists of two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expand the business – both geographically and product wise. ADDvise Group’s shares are listed on Nasdaq First North Growth Market and Mangold Fondkommission AB, +46 8 503 015 50, CA@mangold.se, is the Company's Certified Adviser. Additional information is available at www.addvisegroup.com.

Latest press releases

ADDvise announces preliminary result for 2022 which is stronger than expected

Regulatory

The preliminary result for ADDvise Group for the full year 2022 significantly deviates from what ADDvise Group considers to be current market expectations. [image] The net sales pro forma full year 2022 rolling 12 months amounted to SEK 1,097 million with an adjusted EBITDA pro forma of SEK 241 million. The financial targets for the…

ADDvise receives order worth USD 3.5 million

Regulatory

ADDvise Group AB’s subsidiary Poly Pharmaceuticals Inc has received an order from AxisCare Health Logistics Inc, a company distributing equipment and medical supplies to hospitals, clinics, medical offices and medical equipment suppliers. The order is worth approximately USD 3.5 million. The order consists of delivery of the prescription dietary supplemental Folite, developed and manufactured by…

ADDvise receives order worth USD 1.8 million

Regulatory

ADDvise Group AB’s subsidiary MRC Systems FZE has received an order from Nasser Saeed Al Hajri & Partners Contracting (NHS & Partners), a leading construction contractor in the United Arab Emirates. The order is worth approximately USD 1.8 million. The order involves the detailed design, supply and installation of an ISO 8 and ISO 7…